Literature DB >> 25993969

Wild-type microglia do not reverse pathology in mouse models of Rett syndrome.

Jieqi Wang1, Jan Eike Wegener2, Teng-Wei Huang3, Smitha Sripathy4, Hector De Jesus-Cortes5, Pin Xu6, Stephanie Tran1, Whitney Knobbe1, Vid Leko4, Jeremiah Britt7, Ruth Starwalt8, Latisha McDaniel7, Chris S Ward9, Diana Parra9, Benjamin Newcomb4, Uyen Lao4, Cynthia Nourigat4, David A Flowers4, Sean Cullen10, Nikolas L Jorstad11, Yue Yang11, Lena Glaskova11, Sébastien Vingeau, Sebastian Vigneau12, Julia Kozlitina13, Michael J Yetman14, Joanna L Jankowsky14, Sybille D Reichardt15, Holger M Reichardt15, Jutta Gärtner2, Marisa S Bartolomei12, Min Fang16, Keith Loeb16, C Dirk Keene11, Irwin Bernstein4, Margaret Goodell17, Daniel J Brat18, Peter Huppke2, Jeffrey L Neul19, Antonio Bedalov20, Andrew A Pieper21.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25993969      PMCID: PMC4684952          DOI: 10.1038/nature14444

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  10 in total

1.  A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome.

Authors:  J Guy; B Hendrich; M Holmes; J E Martin; A Bird
Journal:  Nat Genet       Date:  2001-03       Impact factor: 38.330

2.  A new type of microglia gene targeting shows TAK1 to be pivotal in CNS autoimmune inflammation.

Authors:  Tobias Goldmann; Peter Wieghofer; Philippe F Müller; Yochai Wolf; Diana Varol; Simon Yona; Stefanie M Brendecke; Katrin Kierdorf; Ori Staszewski; Moumita Datta; Tom Luedde; Mathias Heikenwalder; Steffen Jung; Marco Prinz
Journal:  Nat Neurosci       Date:  2013-09-29       Impact factor: 24.884

3.  A call for transparent reporting to optimize the predictive value of preclinical research.

Authors:  Story C Landis; Susan G Amara; Khusru Asadullah; Chris P Austin; Robi Blumenstein; Eileen W Bradley; Ronald G Crystal; Robert B Darnell; Robert J Ferrante; Howard Fillit; Robert Finkelstein; Marc Fisher; Howard E Gendelman; Robert M Golub; John L Goudreau; Robert A Gross; Amelie K Gubitz; Sharon E Hesterlee; David W Howells; John Huguenard; Katrina Kelner; Walter Koroshetz; Dimitri Krainc; Stanley E Lazic; Michael S Levine; Malcolm R Macleod; John M McCall; Richard T Moxley; Kalyani Narasimhan; Linda J Noble; Steve Perrin; John D Porter; Oswald Steward; Ellis Unger; Ursula Utz; Shai D Silberberg
Journal:  Nature       Date:  2012-10-11       Impact factor: 49.962

4.  Perivascular, but not parenchymal, cerebral engraftment of donor cells after non-myeloablative bone marrow transplantation.

Authors:  Yue Yang; Nikolas L Jorstad; Christine Shiao; Makenzie K Cherne; Shawn B Khademi; Kathleen S Montine; Thomas J Montine; C Dirk Keene
Journal:  Exp Mol Pathol       Date:  2013-04-06       Impact factor: 3.362

5.  Insulinotropic treatments exacerbate metabolic syndrome in mice lacking MeCP2 function.

Authors:  Meagan R Pitcher; Christopher S Ward; E Melissa Arvide; Christopher A Chapleau; Lucas Pozzo-Miller; Andreas Hoeflich; Manaswini Sivaramakrishnan; Stefanie Saenger; Friedrich Metzger; Jeffrey L Neul
Journal:  Hum Mol Genet       Date:  2013-03-05       Impact factor: 6.150

6.  A macrophage colony-stimulating factor receptor-green fluorescent protein transgene is expressed throughout the mononuclear phagocyte system of the mouse.

Authors:  R Tedjo Sasmono; Delvac Oceandy; Jeffrey W Pollard; Wei Tong; Paul Pavli; Brandon J Wainwright; Michael C Ostrowski; S Roy Himes; David A Hume
Journal:  Blood       Date:  2002-09-12       Impact factor: 22.113

7.  Readthrough of nonsense mutations in Rett syndrome: evaluation of novel aminoglycosides and generation of a new mouse model.

Authors:  Cornelia Brendel; Valery Belakhov; Hauke Werner; Eike Wegener; Jutta Gärtner; Igor Nudelman; Timor Baasov; Peter Huppke
Journal:  J Mol Med (Berl)       Date:  2010-12-01       Impact factor: 4.599

8.  Wild-type microglia arrest pathology in a mouse model of Rett syndrome.

Authors:  Noël C Derecki; James C Cronk; Zhenjie Lu; Eric Xu; Stephen B G Abbott; Patrice G Guyenet; Jonathan Kipnis
Journal:  Nature       Date:  2012-03-18       Impact factor: 49.962

Review 9.  Preclinical research in Rett syndrome: setting the foundation for translational success.

Authors:  David M Katz; Joanne E Berger-Sweeney; James H Eubanks; Monica J Justice; Jeffrey L Neul; Lucas Pozzo-Miller; Mary E Blue; Diana Christian; Jacqueline N Crawley; Maurizio Giustetto; Jacky Guy; C James Howell; Miriam Kron; Sacha B Nelson; Rodney C Samaco; Laura R Schaevitz; Coryse St Hillaire-Clarke; Juan L Young; Huda Y Zoghbi; Laura A Mamounas
Journal:  Dis Model Mech       Date:  2012-11       Impact factor: 5.758

Review 10.  The relationship of Rett syndrome and MECP2 disorders to autism.

Authors:  Jeffrey Lorenz Neul
Journal:  Dialogues Clin Neurosci       Date:  2012-09       Impact factor: 5.986

  10 in total
  58 in total

Review 1.  Genes, circuits, and precision therapies for autism and related neurodevelopmental disorders.

Authors:  Mustafa Sahin; Mriganka Sur
Journal:  Science       Date:  2015-10-15       Impact factor: 47.728

Review 2.  Central nervous system myeloid cells as drug targets: current status and translational challenges.

Authors:  Knut Biber; Thomas Möller; Erik Boddeke; Marco Prinz
Journal:  Nat Rev Drug Discov       Date:  2015-12-04       Impact factor: 84.694

Review 3.  Altered trajectories of neurodevelopment and behavior in mouse models of Rett syndrome.

Authors:  Elizabeth S Smith; Dani R Smith; Charlotte Eyring; Maria Braileanu; Karen S Smith-Connor; Yew Ei Tan; Amanda Y Fowler; Gloria E Hoffman; Michael V Johnston; Sujatha Kannan; Mary E Blue
Journal:  Neurobiol Learn Mem       Date:  2018-11-29       Impact factor: 2.877

4.  Screen for reactivation of MeCP2 on the inactive X chromosome identifies the BMP/TGF-β superfamily as a regulator of XIST expression.

Authors:  Smitha Sripathy; Vid Leko; Robin L Adrianse; Taylor Loe; Eric J Foss; Emily Dalrymple; Uyen Lao; Tonibelle Gatbonton-Schwager; Kelly T Carter; Bernhard Payer; Patrick J Paddison; William M Grady; Jeannie T Lee; Marisa S Bartolomei; Antonio Bedalov
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-31       Impact factor: 11.205

5.  Corrigendum: Wild-type microglia do not reverse pathology in mouse models of Rett syndrome.

Authors:  Jieqi Wang; Jan Eike Wegener; Teng-Wei Huang; Smitha Sripathy; Hector De Jesus-Cortes; Pin Xu; Stephanie Tran; Whitney Knobbe; Vid Leko; Jeremiah Britt; Ruth Starwalt; Latisha McDaniel; Chris S Ward; Diana Parra; Benjamin Newcomb; Uyen Lao; Cynthia Nourigat; David A Flowers; Sean Cullen; Nikolas L Jorstad; Yue Yang; Lena Glaskova; Sébastien Vigneau; Julia Kozlitina; Michael J Yetman; Joanna L Jankowsky; Sybille D Reichardt; Holger M Reichardt; Jutta Gärtner; Marisa S Bartolomei; Min Fang; Keith Loeb; C Dirk Keene; Irwin Bernstein; Margaret Goodell; Daniel J Brat; Peter Huppke; Jeffrey L Neul; Antonio Bedalov; Andrew A Pieper
Journal:  Nature       Date:  2015-07-15       Impact factor: 49.962

Review 6.  Microglia in steady state.

Authors:  Katrin Kierdorf; Marco Prinz
Journal:  J Clin Invest       Date:  2017-07-17       Impact factor: 14.808

Review 7.  Small cells with big implications: Microglia and sex differences in brain development, plasticity and behavioral health.

Authors:  Lars H Nelson; Angela I Saulsbery; Kathryn M Lenz
Journal:  Prog Neurobiol       Date:  2018-09-05       Impact factor: 11.685

Review 8.  Microglia across the lifespan: from origin to function in brain development, plasticity and cognition.

Authors:  Tuan Leng Tay; Julie C Savage; Chin Wai Hui; Kanchan Bisht; Marie-Ève Tremblay
Journal:  J Physiol       Date:  2016-05-29       Impact factor: 5.182

9.  Pooled shRNA Screen for Reactivation of MeCP2 on the Inactive X Chromosome.

Authors:  Vid Leko; Smitha Sripathy; Robin L Adrianse; Taylor Loe; Angela Park; Uyen Lao; Eric J Foss; Marisa S Bartolomei; Antonio Bedalov
Journal:  J Vis Exp       Date:  2018-03-02       Impact factor: 1.355

Review 10.  The Role of Microglia in Neurodevelopmental Disorders and their Therapeutics.

Authors:  Rachel Coomey; Rianne Stowell; Ania Majewska; Daniela Tropea
Journal:  Curr Top Med Chem       Date:  2020       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.